Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Apr;9(2):180-183.
doi: 10.21037/tlcr.2020.03.07.

From precision medicine to imprecision medicine through limited diagnostic ability to detect low allelic frequency mutations

Affiliations
Editorial

From precision medicine to imprecision medicine through limited diagnostic ability to detect low allelic frequency mutations

María José Serrano et al. Transl Lung Cancer Res. 2020 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tlcr.2020.03.07). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Sensitivity assessment of matrix-assisted laser time-of-flight desorption/ionization (MALDI-TOF), allele-specific polymerase chain reaction (AS-PCR) and droplet digital PCR (ddPCR) detecting low allelic frequencies in epithelial growth factor receptor (EGFR) gene and their influence selecting a more precise treatment. Abbreviations are: TKI, tyrosine kinase inhibitors; mAF, mutated allele frequency.

Comment on

References

    1. Auffray C, Charron D, Hood L. Predictive, preventive, personalized and participatory medicine: back to the future. Genome Med 2010;2:57. 10.1186/gm178 - DOI - PMC - PubMed
    1. Wang JF, Pu X, Zhang X, et al. Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing. Cancer 2018;124:1061-9. 10.1002/cncr.31152 - DOI - PMC - PubMed
    1. Jiang W, Cai G, Hu PC, et al. Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective. Acta Pharm Sin B 2018;8:530-8 10.1016/j.apsb.2018.04.005 - DOI - PMC - PubMed
    1. Lettig L, Sahnane N, Pepe F, et al. EGFR T790M detection rate in lung adenocarcinomas at baseline using droplet digital PCR and validation by ultra-deep next generation sequencing. Transl Lung Cancer Res 2019;8:584-92. 10.21037/tlcr.2019.09.18 - DOI - PMC - PubMed
    1. Sherwood JL, Müller S, Orr MCM, et al. Panel Based MALDI-TOF Tumour Profiling Is a Sensitive Method for Detecting Mutations in Clinical Non Small Cell Lung Cancer Tumour. Lo AW, editor. PLoS One 2014;9:e100566. - PMC - PubMed